238 related articles for article (PubMed ID: 6580841)
1. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of vindesine in patients with hematological malignancies.
Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
[TBL] [Abstract][Full Text] [Related]
3. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
4. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
[TBL] [Abstract][Full Text] [Related]
5. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
[TBL] [Abstract][Full Text] [Related]
6. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
7. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of Vindesine in patients with hematological malignancy].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
[TBL] [Abstract][Full Text] [Related]
10. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
[TBL] [Abstract][Full Text] [Related]
11. Initial clinical studies of vindesine.
Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
[TBL] [Abstract][Full Text] [Related]
12. m-AMSA: phase II trial in advanced lymphoma and leukemia.
Case DC
Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
Miller TP; Jones SE; Chester A
Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
[TBL] [Abstract][Full Text] [Related]
14. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
Mathé G; Misset JL; De Vassal F; Gouveia J; Hayat M; Machover D; Belpomme D; Pico JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; De Luca L
Cancer Treat Rep; 1978 May; 62(5):805-9. PubMed ID: 274996
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
Jehn U; Mezger J
Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
18. Vindesine in the treatment of esophageal carcinoma: a phase II study.
Kelsen DP; Bains M; Cvitkovic E; Golbey R
Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
Hellriegel KP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
[No Abstract] [Full Text] [Related]
20. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
